Gemfibrozil causes large increases in the AUCs of
pioglitazone and
rosiglitazone.
The
clinical relevance of this interaction has not been assessed. Until further experience is gained, caution is warranted. Consider an increased frequency of blood glucose monitoring when the combination is first started.